Michael Killpack
Internal Medicine · Sandy, UTNPI 1588714091
Payments from drug & device makers
Across 518 payments — averaging $3867.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$495K
- Eisai Inc.$320K
- Sebela Pharmaceuticals Inc.$248K
- Mitsubishi Tanabe Pharma Development America, Inc.$231K
- Biohaven Pharmaceuticals, Inc.$221K
- AstraZeneca$111K
- plus $378K from 32 others
Across 3 payments — averaging $1801.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,003,377 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.
Other internal medicine in Sandy
- Barbara RizzardiSandy$27.8M
- Ahad SabetSalt Lake City$34.5M
- Willard DereSalt Lake City$4.7M
- Joseph WoolleySaint George$3.6M
- Justin MansfieldOgden$3.1M
- Cuper Martinez SantibanezWest Valley City$1M
- Joshua OaksBountiful$973K
- Brandon WebbSalt Lake City$544K
- Yong Hui AhnSlc$474K
- Larry StakerSalt Lake City$441K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.